• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
RE: Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study.关于：携带种系BRCA1或BRCA2突变女性的子宫内膜癌风险：多中心队列研究。
J Natl Cancer Inst. 2022 Feb 7;114(2):320-321. doi: 10.1093/jnci/djab154.
2
Endometrial Cancer, BRCA1, and BRCA2 in the UK Biobank Cohort.英国生物库队列中的子宫内膜癌、BRCA1 和 BRCA2
Am J Clin Oncol. 2021 Jul 1;44(7):299-300. doi: 10.1097/COC.0000000000000833.
3
BRCA1 and BRCA2 pathogenic variant carriers and endometrial cancer risk: A cohort study.BRCA1和BRCA2致病变异携带者与子宫内膜癌风险：一项队列研究。
Eur J Cancer. 2020 Sep;136:169-175. doi: 10.1016/j.ejca.2020.05.030. Epub 2020 Jul 19.
4
A population-based analysis of germline BRCA1 and BRCA2 testing among ovarian cancer patients in an era of histotype-specific approaches to ovarian cancer prevention.基于人群的分析显示，在针对卵巢癌预防的组织类型特异性方法时代，卵巢癌患者的种系 BRCA1 和 BRCA2 检测情况。
BMC Cancer. 2018 Mar 5;18(1):254. doi: 10.1186/s12885-018-4153-8.
5
The clinical importance of BRCAness in a population-based cohort of Danish epithelial ovarian cancer.BRCAness 在丹麦基于人群的上皮性卵巢癌队列中的临床重要性。
Int J Gynecol Cancer. 2019 Jan;29(1):166-173. doi: 10.1136/ijgc-2018-000017.
6
Endometrial Cancer in Germline BRCA Mutation Carriers: A Systematic Review and Meta-analysis.遗传性 BRCA 基因突变携带者的子宫内膜癌：系统评价和荟萃分析。
J Minim Invasive Gynecol. 2021 May;28(5):947-956. doi: 10.1016/j.jmig.2020.11.023. Epub 2020 Nov 27.
7
Anti-Müllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations.携带种系BRCA1或BRCA2突变女性的抗苗勒管激素血清浓度。
Hum Reprod. 2016 May;31(5):1126-32. doi: 10.1093/humrep/dew044.
8
Germline Mutation Status, Pathological Complete Response, and Disease-Free Survival in Triple-Negative Breast Cancer: Secondary Analysis of the GeparSixto Randomized Clinical Trial.三阴性乳腺癌中的胚系突变状态、病理完全缓解和无病生存：GeparSixto 随机临床试验的二次分析。
JAMA Oncol. 2017 Oct 1;3(10):1378-1385. doi: 10.1001/jamaoncol.2017.1007.
9
Report of Endometrial Cancer in Australian BRCA1 and BRCA2 mutation-positive Families.澳大利亚BRCA1和BRCA2基因突变阳性家族中的子宫内膜癌报告。
Twin Res Hum Genet. 2011 Apr;14(2):111-8. doi: 10.1375/twin.14.2.111.
10
Targeted sequencing of BRCA1 and BRCA2 across a large unselected breast cancer cohort suggests that one-third of mutations are somatic.对一大组未经选择的乳腺癌队列进行BRCA1和BRCA2的靶向测序表明，三分之一的突变是体细胞突变。
Ann Oncol. 2016 Aug;27(8):1532-8. doi: 10.1093/annonc/mdw209. Epub 2016 May 18.

引用本文的文献

1
Risk-Reducing Breast and Gynecological Surgery for BRCA Mutation Carriers: A Narrative Review.BRCA 突变携带者的降低风险的乳腺和妇科手术：一篇叙述性综述。
J Clin Med. 2023 Feb 10;12(4):1422. doi: 10.3390/jcm12041422.
2
Response to Nahshon and Lavie.对纳赫松和拉维的回应。
J Natl Cancer Inst. 2022 Feb 7;114(2):322-323. doi: 10.1093/jnci/djab155.

本文引用的文献

1
Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study.携带胚系 BRCA1 或 BRCA2 突变的女性的子宫内膜癌风险：多中心队列研究。
J Natl Cancer Inst. 2021 Sep 4;113(9):1203-1211. doi: 10.1093/jnci/djab036.
2
BRCA1/2 and Endometrial Cancer Risk: Implications for Management.BRCA1/2与子宫内膜癌风险：对治疗的启示
J Natl Cancer Inst. 2021 Sep 4;113(9):1127-1128. doi: 10.1093/jnci/djab037.
3
Should the risk for uterine cancer influence decision making for prophylactic hysterectomy in BRCA1/2 mutated patients- a systematic review and meta-analysis.BRCA1/2 突变患者行预防性子宫切除术时，是否应考虑患子宫癌的风险——系统评价和荟萃分析。
Gynecol Oncol. 2021 Mar;160(3):755-762. doi: 10.1016/j.ygyno.2020.11.034. Epub 2020 Dec 10.
4
PARP Inhibitors in Endometrial Cancer: Current Status and Perspectives.PARP抑制剂在子宫内膜癌中的现状与展望
Cancer Manag Res. 2020 Jul 22;12:6123-6135. doi: 10.2147/CMAR.S221001. eCollection 2020.
5
The clinical characteristics and prognosis of endometrial carcinomas that occur after breast cancer: does hormone receptor status of breast cancer matter?乳腺癌后发生的子宫内膜癌的临床特征和预后：乳腺癌的激素受体状态是否重要？
Arch Gynecol Obstet. 2019 Nov;300(5):1399-1404. doi: 10.1007/s00404-019-05318-2. Epub 2019 Oct 1.
6
Frequent Homologous Recombination Deficiency in High-grade Endometrial Carcinomas.高频同源重组缺陷与高级别子宫内膜癌。
Clin Cancer Res. 2019 Feb 1;25(3):1087-1097. doi: 10.1158/1078-0432.CCR-18-1443. Epub 2018 Nov 9.
7
Association between uterine serous carcinoma and breast cancer.子宫浆液性癌与乳腺癌之间的关联。
Gynecol Oncol. 2004 Jul;94(1):208-11. doi: 10.1016/j.ygyno.2004.04.009.

RE: Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study.

作者信息

Nahshon Chen, Lavie Ofer

机构信息

Department of Gynecological Oncology, Carmel Medical Center, Haifa affiliated to the Technion, Haifa, Israel.

出版信息

J Natl Cancer Inst. 2022 Feb 7;114(2):320-321. doi: 10.1093/jnci/djab154.

DOI:10.1093/jnci/djab154
PMID:34424329
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8826471/
Abstract
摘要